Invitation: Roche Diagnostics Investor Day 2024 Mittwoch, 10. April 2024 - 14:40

The Roche Investor Relations team would like to invite you to the Roche Diagnostics Investor Day that will take place in London on Wednesday, 22 May 2024, starting at 12:00 BST local time and will finish at 15:30 BST with a reception.

The Roche Diagnostics Investor Day will address the following topics:

• Mass spectrometry
• Continuous glucose monitoring
• Next generation sequencing
• Point of care
• Upcoming molecular diagnostics launches
• Neurology biomarkers in development

Presenters include:
Matt Sause, CEO Roche Diagnostics
Alan Hippe, Chief Financial and IT Officer
Palani Kumaresan, Global Head of Roche Diagnostics Solutions (RDS)
Benjamin Lilienfeld, Lifecycle Leader Serum Work Area Systems
Jochen Berchtold, Franchise Lead Insulin Therapy Solutions
Ildiko Amann-Zalan, Head of Research & Development Roche Diagnostics Solutions
Nico Michel, Lifecycle Leader Infectious Diseases - Molecular Lab
Olivier Gillieron, Lifecycle Leader Cardiometabolic and Neurology

Meeting information:

Date/Time (BST):
Wednesday, 22 May 2024
12:00 - 13:00 Registration and lunch
13:00 - 15:30 Presentations & Q&A
15:30 - 16:15 Refreshments with Roche Management Team

Venue
Convene (formerly etc venues)
133 Houndsditch
London EC3A 7BX
> map

To register for the event, please follow this > link (passcode: Dia2024).

The slides will be available for download at 12:00 BST on the day of the event.
> click here

Alternatively you may participate virtually in the webinar (no access to speakers, pre-registration required). Please pre-register for the webinar here*.

Should you be unable to register for the webinar due to your company IT policy, please send an e-mail to investor.relations@roche.com .

A replay of the event will be available via > ir.roche.com

*privacy notice

Best regards,

Bruno Eschli
Head of Investor Relations

Birgit Masjost

Investor Relations Officer

Roche Investor Relations

Dr. Bruno Eschli

Phone: +41 61 68-75284

e-mail: bruno.eschli@roche.com

Dr. Sabine Borngräber

Phone: +41 61 68-88027

e-mail: sabine.borngraeber@roche.com

Dr. Birgit Masjost

Phone: +41 61 68-84814

e-mail: birgit.masjost@roche.com

Investor Relations North America

Loren Kalm

Phone: +1 650 225 3217

e-mail: kalm.loren@gene.com